Literature DB >> 26495259

Chronic Administration of High Doses of Nandrolone Decanoate on the Pituitary-Gonadal Axis in Male Rats.

Mohammad Reza Shahraki1, Hamideh Mirshekari2, Ahmad Reza Shahraki3.   

Abstract

BACKGROUND: Anabolic-androgenic steroids (AAS) are abused by athletes.
OBJECTIVES: The present study was designed to evaluate chronic administration of high doses of nandrolone decanoate (ND) on the pituitary-gonadal axis and hematological parameters in normal male rats.
MATERIALS AND METHODS: Thirty Wistar-Albino male rats were divided assigned to control (C), placebo (P) and test (T) groups (n = 10). Group T received 15 mg/kg intramuscular (IM) ND for eight weeks. Group P received the same volume of peanut oil, but group C did not receive any agent during the trial period. At the end, animals were anesthetized, killed and blood samples collected from cervical vessels. Serum follicle stimulating hormone (FSH) and luteinizing hormone (LH) levels were determined by sensitive rat gonadotropins kit, using ELISA methods. Serum testosterone and hematological parameters were measured by ordinary laboratory methods. Obtained data was analyzed using SPSS 17 by ANOVA and Tukey statistical tests. Results were expressed as Mean ± SD. Statistical difference considered significantly by P < 0.05.
RESULTS: Serum testosterone, LH, FSH, weight gain, food and water intake in group T were significantly decreased compared to other groups (P < 0.05). In addition erythrocyte, leucocytes, hemoglobin and hematocrit in group T were significantly increased compared to those of other groups (P < 0.05).
CONCLUSIONS: Chronic administration of high doses of ND can alter serum FSH, LH and testosterone and hematological parameters in male rats.

Entities:  

Keywords:  Nandrolone Decanoate; Rats; Testosterone

Year:  2015        PMID: 26495259      PMCID: PMC4609496          DOI: 10.5812/ijhrba.24419

Source DB:  PubMed          Journal:  Int J High Risk Behav Addict        ISSN: 2251-8711


1. Background

Nandrolone decanoate (ND) is an anabolic-androgenic steroid (AAS) used by athletes to improve their athletic ability and muscle mass (1). Anabolic-androgen steroids had various benefits for patients with anemia (2). Administration of ND for six months could increase hemoglobin and hematocrit in anemic men (3). Chronic AAS administration may alter the melanocortin system activity and appetite and food intake in rats (4). Studies showed that chronic administration of ND induces deep changes to mental health in rats (5) and causes DNA damage in leukocytes, liver, bone marrow, brain and testicle cells in mice (6). Sex steroid hormones can have a direct performance on the pituitary, follicle stimulating hormone (FSH) and luteinizing hormone (LH) secretion (7). Androgenized female rats showed alteration in the morphometric thickness of the luminal epithelium, myometrium and perimetrium associated with infertility when treated with steroids in the pre-gestational period (8).

2. Objectives

Since ND is abused by athletes and youth, the aim of the present study was to evaluate the effect of high doses of ND administration on serum FSH, LH, weight gain, food and water intake and hematological parameters in male rats.

3. Materials and Methods

Animals: This experiment was performed on 30 Wistar-Albino male rats, weighing 200-230 grams kept in Zahedan University of Medical Sciences animal house and distinctly housed in cages. The present study received institutional ethical approval from the animal research committee of Zahedan University of Medical Sciences (issued 89-2362). After a week, animals were weighed by EK-b10 Japan digital balance (first weight) and divided into three groups randomly as follows; control (C), placebo (P) and test (T) groups (n = 10): Group T received 15 mg/kg IM, ND for eight weeks (4) daily, but group P received the same volume of Peanut oil during the trial period. Group C did not receive any agents in experimental period.

3.1. Drug Preparation

ND Iran Hormone (L.P.D.I.C) was purchased from a city drugstore and sustained in the appropriate temperature.

3.2. Collection of Blood Samples

At the end of trial period, animals were weighted (final weight) and deeply anesthetized by diethyl ether (Merck Germany), killed and blood samples were collected from cervical vessels. At first, blood samples were collected in CBC tube (coated with EDTA) for hematological parameters measurements. Residual blood samples were collected in ordinary vials and centrifuged at 3000 rpm for 10 minutes to separate serum. Serum was removed (BH-1200 type Iran) and stored at -70°C for further analyses.

3.3. Measurements

Serum FSH and LH were measured by sensitive rat kit (Cusabio Biotech Co. LTD, China), using ELISA method. Serum testosterone was measured by standard laboratory (Mino bine human kit USA) methods. Hematological parameters measured by usual laboratory methods.

3.4. Statistical Tests

Obtained data was analyzed using SPSS 17 (IBM, New York, USA) by ANOVA and Tukey tests. Results were expressed as mean ± SD. Statistical difference considered significant at P < 0.05.

4. Results

Serum Testosterone, LH and FSH levels in group T were significantly decreased compared to those of C and P groups (Table 1, P < 0.05). Moreover, weight gain, food and water intake in group T were significantly decreased compared to those of C and P groups (Table 2, P < 0.05). In addition, erythrocytes, leucocytes, hemoglobin, hematocrit and platelet levels in group T were significantly increased compared to those of C and P groups (Table 2, P < 0.05).
Table 1.

Chronic Administration of High Doses of ND on FSH, LH and Testosterone in Male Rats [a,b]

ParametersGroupsP Value
CPT
FSH, IU/L 28.11 ± 2.8929.19 ± 4.7322.17 ± 2.19 [c]P < 0.002
LH, IU/L 8.21 ± 3.539.41 ± 1.924.82 ± 1.62 [c]P < 0.001
Testosterone, μg/dL 4.62 ± 2.395.11 ± 1.201.09 ± 0.58 [c]P < 0.02

a Abbreviations: C, cotrol; FSH, follicle stimulating hormone; LH, Luteinizing hormone; P, Plasebo; and T, Test.

b Based on ANOVA and Tukey test, FSH, LH and testosterone values in group T were significantly decreased compared to those of C and P groups.

c P < 0.05; n = 10.

Table 2.

Chronic Administration of High Doses of ND on Weight Gain, Food, Water Intake and Hematological Parameters in Male Rats [a,b]

ParametersGroupsP Value
CPT
Weight, g 239.6 ± 13.5237.9 ± 11.6212.4 ± 11.6 [c]P < 0.001
Food intake, g 15.1 ± 1.915.6 ± 1.114.1 ± 1.3 [c]p < 0.002
Water intake, mL 43.4 ± 4.444.6 ± 2.340.6 ± 2.3 [c]P < 0.02
Hemoglobin, gr/dL 14.5 ± 2.214.82 ± 5116.41 ± 1.21 [c]P < 0.03
Leucocytes, cell/μL 7200 ± 80069200 ± 9708600 ± 1100 [c]P < 0.01
Erythrocyte, mL/ μL 5.81 ± 1.25.22 ± 1.26.95 ± 1.3 [c]P < 0.01
Hematocrit, % 43 ± 443 ± 348 ± 4 [c]P < 0.01
Platelets, 1000cell/μL 230 ± 34228 ± 30320 ± 42 [c]P < 0.02

a Abbreviations: C, Cotrol; P, Plasebo; and T, Test.

b Based on ANOVA and Tukey tests, weight gain, food and water intake values in group T were significantly decreased compared to those of group C, but hematological parameters were increased compared to other groups.

c P < 0.05; n = 10.

a Abbreviations: C, cotrol; FSH, follicle stimulating hormone; LH, Luteinizing hormone; P, Plasebo; and T, Test. b Based on ANOVA and Tukey test, FSH, LH and testosterone values in group T were significantly decreased compared to those of C and P groups. c P < 0.05; n = 10. a Abbreviations: C, Cotrol; P, Plasebo; and T, Test. b Based on ANOVA and Tukey tests, weight gain, food and water intake values in group T were significantly decreased compared to those of group C, but hematological parameters were increased compared to other groups. c P < 0.05; n = 10.

5. Discussion

Chronic administration of ND at high dose decreased plasma FSH, LH, testosterone, weight gain and food and water intake in male rats. In addition, erythrocytes; hemoglobin, hematocrit, Leukocyte and platelets values were increased in group T. High doses of AAS used for athletic enhancement can lead to irreversible organ damage such as reduced fertility and gynecomastia in males (9). Moreover, AAS has a high affinity for the androgen receptor in central and peripheral tissues and causes impairments in hypothalamicpituitary-gonadal axis (9). In addition, Kuhn CM reported that AAS affects androgen receptors and alters enzymatic aromatization of testosterone derivatives to increase its affinity to estrogen receptors (10). Our finding exposed that ND decreased serum LH and testosterone secretion in the group T. These results are the same as Alsio (11), which reported that AAS administration was probable to reduce hypothalamic-pituitary-gonadal axis activity by affecting physiological feedback mechanisms. Bijlsma et al. (7) in a pilot study found that ND administration in male patients with rheumatoid arthritis caused significant decreases in serum Testosterone and FSH levels. Our findings showed that FSH value in group T was significantly deceased compared to that of other groups and it was the same as literature study (10). Oda and El-Ashmawy (12) reported that chronic administration of ND caused decrease in testes and epididymis weights, but did not show any significant changes in weight gain in normal rabbits. Our results are different with that of Oda and El-Ashmawy (12). This difference is probably due to different used animals. Our findings were in accordance with the theory that sex steroids hormones can act directly on the hypothalamus- pituitary-testis axis and resulting in selective FSH and LH secretion (8). In addition, our outcome was in agreement with that of Shokri et al. (13), which revealed that exercise training increases the amount of apoptosis in the spermatogenic cell lineage by supraphysiological dose of ND in rats. Our study revealed that weight gain, food and water intake in group T were significantly decreased compared to those of other groups, which is in accordance with the literature (14). Bhasin et al. (14) found that erythrocytes, hemoglobin and hematocrit were improved dose dependently in healthy men aged 18 to 50 years who received AAS and changes in levels of hemoglobin and hematocrit were related to changes in testosterone concentrations compared to those of placebo group. In the present study, erythrocyte, hemoglobin, hematocrit, leukocyte and platelets values in group T were significantly increased compared to those of other groups and confirmed by another investigation (14). This is presumably because chronic ND administration in the present study increased metabolism, serum erythropoietin concentration and stimulated hematopoiesis in bone marrow. In conclusion, chronic administration of high doses of ND administration could alter serum FSH, LH, testosterone, weight gain, food and water intake and hematological parameters in male rats.
  14 in total

1.  Exercise and supraphysiological dose of nandrolone decanoate increase apoptosis in spermatogenic cells.

Authors:  Saeed Shokri; Robert John Aitken; Mirabbas Abdolvahhabi; Farid Abolhasani; Fahimeh Mohammad Ghasemi; Iraj Kashani; Shahram Ejtemaeimehr; Shahin Ahmadian; Bagher Minaei; Mohammad Ali Naraghi; Mohammad Barbarestani
Journal:  Basic Clin Pharmacol Toxicol       Date:  2009-12-07       Impact factor: 4.080

2.  Nandrolone androgenic hormone presents genotoxic effects in different cells of mice.

Authors:  Carolina Almeida do Carmo; Álvaro Luiz Martini Gonçalves; Daisy Maria Fávero Salvadori; Edson Luis Maistro
Journal:  J Appl Toxicol       Date:  2011-06-30       Impact factor: 3.446

3.  Chronic administration of the anabolic androgenic steroid nandrolone alters neurosteroid action at the sigma-1 receptor but not at the sigma-2 or NMDA receptors.

Authors:  Martin Elfverson; Tobias Johansson; Qin Zhou; Pierre Le Grevès; Fred Nyberg
Journal:  Neuropharmacology       Date:  2011-01-18       Impact factor: 5.250

Review 4.  Anabolic steroids.

Authors:  Cynthia M Kuhn
Journal:  Recent Prog Horm Res       Date:  2002

5.  Detection of nandrolone, testosterone, and their esters in rat and human hair samples.

Authors:  K M Höld; C R Borges; D G Wilkins; D E Rollins; R E Joseph
Journal:  J Anal Toxicol       Date:  1999-10       Impact factor: 3.367

6.  Nandrolone decanoate is a good alternative for the treatment of anemia in elderly male patients on hemodialysis.

Authors:  A Gascón; J J Belvis; F Berisa; E Iglesias; V Estopiñán; J L Teruel
Journal:  Geriatr Nephrol Urol       Date:  1999

7.  Anabolic androgenic steroid nandrolone decanoate reduces hypothalamic proopiomelanocortin mRNA levels.

Authors:  Jonas Lindblom; Anna M S Kindlundh; Fred Nyberg; Lena Bergström; Jarl E S Wikberg
Journal:  Brain Res       Date:  2003-10-03       Impact factor: 3.252

8.  [Effects of androgenic anabolic steroids on the uterus and reproductive parameters of adult female rats].

Authors:  Isabel Cristina Cherici Camargo; Ana Luisa Camolezi Gaspar; Fernando Frei; Suzana de Fátima Paccola Mesquita
Journal:  Rev Bras Ginecol Obstet       Date:  2009-09

9.  Influence of nandrolondecanoate on the pituitary-gonadal axis in males.

Authors:  J W Bijlsma; S A Duursma; J H Thijssen; O Huber
Journal:  Acta Endocrinol (Copenh)       Date:  1982-09

10.  Nandrolone decanoate for the treatment of erythropoietin refractory anemia: a case series.

Authors:  Bobby Chawla; Fahad M Iqbal; Manjeet S Chawla
Journal:  Compr Ther       Date:  2009 Fall-Winter
View more
  3 in total

1.  Arrhythmogenic effect of androgens on the rat heart.

Authors:  Mariana Argenziano; Gisela Tiscornia; Rosalia Moretta; Leonardo Casal; Constanza Potilinski; Carlos Amorena; Eduardo Garcia Gras
Journal:  J Physiol Sci       Date:  2016-05-30       Impact factor: 2.781

2.  The opposite effects of nandrolone decanoate and exercise on anxiety levels in rats may involve alterations in hippocampal parvalbumin-positive interneurons.

Authors:  Dragica Selakovic; Jovana Joksimovic; Ivan Zaletel; Nela Puskas; Milovan Matovic; Gvozden Rosic
Journal:  PLoS One       Date:  2017-12-12       Impact factor: 3.240

3.  Nandrolone decanoate interferes with testosterone biosynthesis altering blood-testis barrier components.

Authors:  Rosario Barone; Alessandro Pitruzzella; Antonella Marino Gammazza; Francesca Rappa; Monica Salerno; Fulvio Barone; Claudia Sangiorgi; Daniela D'Amico; Nicola Locorotondo; Francesca Di Gaudio; Luigi Cipolloni; Valentina Di Felice; Stefania Schiavone; Venerando Rapisarda; Gabriele Sani; Amos Tambo; Francesco Cappello; Emanuela Turillazzi; Cristoforo Pomara
Journal:  J Cell Mol Med       Date:  2017-02-28       Impact factor: 5.310

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.